WallStreetZenWallStreetZen

NASDAQ: FATE
Fate Therapeutics Inc Stock Ownership - Who owns Fate Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Fate Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Edward J. Dulac IiiChief Financial Officer2023-08-184,718$2.80
$13.21kSell
Yuan XuDirector2023-08-04632$3.71
$2.34kSell
Brian T. PowlChief Commercial Officer2023-07-053,854$4.87
$18.77kSell
Edward J. Dulac IiiChief Financial Officer2023-07-055,182$4.83
$25.03kSell
Yuan XuDirector2023-06-143,460$5.58
$19.31kSell
Redmile Group LLCDirector2023-04-21256,639$6.18
$1.59MBuy
Redmile Group LLCDirector2023-04-2020,000$5.99
$119.80kBuy
Yuwaye ChuChief Medical Officer2023-04-182,317$6.58
$15.25kSell
Yuwaye ChuChief Medical Officer2023-04-18215$6.52
$1.40kSell
Redmile Group LLCDirector2023-04-1425,700$6.00
$154.20kBuy

1 of 3

FATE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FATE insiders and whales buy or sell their stock.

FATE Shareholders

What type of owners hold Fate Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Redmile Group LLC26.49%26,104,311$55.34MInsider
Redmile Group LLC13.32%13,124,427$27.82MInstitution
Blackrock Inc12.15%11,978,558$25.39MInstitution
Vanguard Group Inc11.89%11,723,374$24.85MInstitution
State Street Corp10.46%10,313,911$21.87MInstitution
Amir Nashat10.00%9,852,967$20.89MInsider
Polaris Venture Management Co V LLC9.99%9,841,933$20.86MInsider
Bellevue Group Ag4.93%4,855,779$10.29MInstitution
D E Shaw Co Inc4.67%4,599,439$9.75MInstitution
Johnson Johnson3.43%3,379,064$7.16MInstitution

1 of 3

FATE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FATE64.94%35.06%Net BuyingNet Selling
FENC3.93%96.07%Net SellingNet Buying
ALLK44.48%55.52%Net SellingNet Selling
LYRA68.02%16.86%Net Buying
TSHA21.26%42.14%Net BuyingNet Buying
View Top Biotech Stocks

Fate Therapeutics Stock Ownership FAQ

Who owns Fate Therapeutics?

Fate Therapeutics (NASDAQ: FATE) is owned by 110.43% institutional shareholders, 59.63% Fate Therapeutics insiders, and 0.00% retail investors. Redmile Group LLC is the largest individual Fate Therapeutics shareholder, owning 26.10M shares representing 26.49% of the company. Redmile Group LLC's Fate Therapeutics shares are currently valued at $50.12M.

If you're new to stock investing, here's how to buy Fate Therapeutics stock.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.